{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:19:05Z","timestamp":1793067545372,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022YFC2504603"],"award-info":[{"award-number":["2022YFC2504603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myostatin and irisin, the key regulators of muscle metabolism, are myokines secreted by skeletal muscles that significantly influence osteoporosis (OP) and sarcopenia. This study investigated the associations of serum myostatin and irisin levels with sarcopenia and OP prevalence in 182 rheumatoid arthritis (RA) versus 142 healthy controls. RA patients exhibited significantly elevated serum myostatin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001) and reduced irisin levels (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.009), with markedly higher rates of myostatin\/irisin dysregulation compared to controls (both\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Subgroup analyses revealed that RA patients with sarcopenia had higher myostatin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.002) and lower irisin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.003) than RA patients without sarcopenia. Similarly, RA patients with osteoporotic fractures (OPF) showed increased myostatin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.045) and decreased irisin (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.029) compared to those without OPF. Myostatin levels correlated positively with anti-cyclic citrullinated peptide (anti-CCP) antibodies (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.041) and inversely with body mass index (BMI) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.003), while irisin levels were negatively associated with C-reactive protein (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.040) and positively linked to skeletal muscle mass index (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.036). Multivariate analyses identified the Sharp score as an independent risk factor for OP (OR\u2009=\u20091.005, 95% CI 1.000\u20131.010;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.04). For sarcopenia, both Sharp score (OR\u2009=\u20091.008, 95% CI 1.002\u20131.014;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.013) and elevated myostatin levels (OR\u2009=\u20091.222, 95% CI 1.015\u20131.472;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.034) were significant risk predictors, whereas higher irisin levels conferred protection (OR\u2009=\u20090.963, 95% CI 0.936\u20130.990;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.007). Elevated serum myostatin and reduced irisin levels are associated with sarcopenia and OPF in RA patients. Sharp scores are identified as a risk factor for OP in RA patients. Additionally, Sharp scores and elevated myostatin levels serve as risk factors for sarcopenia, while irisin levels act as a protective factor against sarcopenia.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-07378-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:57:26Z","timestamp":1751410646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlations of serum myostatin and irisin with sarcopenia and osteoporosis in rheumatoid arthritis patients: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Wan-jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-yan-ran","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-xi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"7378_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023\u20132038 (2016).","journal-title":"Lancet"},{"key":"7378_CR2","doi-asserted-by":"publisher","first-page":"R208","DOI":"10.1186\/ar4401","volume":"15","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. Inhibition of synovitis and joint destruction by a new single domain antibody specific for cyclophilin A in two different mouse models of rheumatoid arthritis. Arthritis Res. Ther. 15, R208 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"7378_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 48, 16\u201331 (2019).","journal-title":"Age Ageing"},{"key":"7378_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","volume":"41","author":"MCK Severinsen","year":"2020","unstructured":"Severinsen, M. C. K. & Pedersen, B. K. Muscle\u2013organ crosstalk: The emerging roles of myokines. Endocr. Rev. 41, 594\u2013609 (2020).","journal-title":"Endocr. Rev."},{"key":"7378_CR5","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/nu12082401","volume":"12","author":"J Baczek","year":"2020","unstructured":"Baczek, J., Silkiewicz, M. & Wojszel, Z. B. Myostatin as a biomarker of muscle wasting and other pathologies-state of the art and knowledge gaps. Nutrients 12, 2401 (2020).","journal-title":"Nutrients"},{"key":"7378_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2044-5040-1-19","volume":"1","author":"TN Burks","year":"2011","unstructured":"Burks, T. N. & Cohn, R. D. Role of TGF-\u03b2 signaling in inherited and acquired myopathies. Skeletal Muscle. 1, 19 (2011).","journal-title":"Skeletal Muscle."},{"key":"7378_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/bonekey.2012.60","volume":"1","author":"MW Hamrick","year":"2012","unstructured":"Hamrick, M. W. The skeletal muscle secretome: an emerging player in muscle\u2013bone crosstalk. BoneKEy Rep. 1, 60 (2012).","journal-title":"BoneKEy Rep."},{"key":"7378_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JES.0b013e318201f601","volume":"39","author":"MW Hamrick","year":"2011","unstructured":"Hamrick, M. W. A role for myokines in muscle-bone interactions. Exerc. Sport Sci. Rev. 39, 43\u201347 (2011).","journal-title":"Exerc. Sport Sci. Rev."},{"key":"7378_CR9","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.1002\/jcp.27665","volume":"234","author":"CM Su","year":"2019","unstructured":"Su, C. M. et al. Myostatin induces tumor necrosis factor-\u03b1 expression in rheumatoid arthritis synovial fibroblasts through the PI3K-Akt signaling pathway. J Cell. Physiol. 234, 9793\u20139801 (2019).","journal-title":"J Cell. Physiol."},{"key":"7378_CR10","doi-asserted-by":"crossref","unstructured":"Gonzalez-Ponce, F. et al. Role of myostatin in rheumatoid arthritis: a review of the clinical impact.\u00a0Diagnostics (Basel). 14, 1085 (2024).","DOI":"10.3390\/diagnostics14111085"},{"key":"7378_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cmet.2015.08.001","volume":"22","author":"MP Jedrychowski","year":"2015","unstructured":"Jedrychowski, M. P. et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 22, 734\u2013740 (2015).","journal-title":"Cell Metab."},{"key":"7378_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41467-017-01131-0","volume":"8","author":"MM Reza","year":"2017","unstructured":"Reza, M. M. et al. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy. Nat. Commun. 8, 1104 (2017).","journal-title":"Nat. Commun."},{"key":"7378_CR13","doi-asserted-by":"publisher","first-page":"18732","DOI":"10.1038\/srep18732","volume":"6","author":"X Qiao","year":"2016","unstructured":"Qiao, X. et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci. Rep. 6, 18732 (2016).","journal-title":"Sci. Rep."},{"key":"7378_CR14","doi-asserted-by":"publisher","first-page":"16056","DOI":"10.1038\/boneres.2016.56","volume":"5","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism. Bone Res. 5, 16056 (2017).","journal-title":"Bone Res."},{"key":"7378_CR15","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","volume":"329","author":"DL Scott","year":"1987","unstructured":"Scott, D. L., Coulton, B. L., Symmons, D. P. M. & Popert, A. J. Long-term outcome of treating rheumatoid arthritis: Results after 20 years. The Lancet 329, 1108\u20131111 (1987).","journal-title":"The Lancet"},{"key":"7378_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580\u20131588 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"7378_CR17","doi-asserted-by":"publisher","first-page":"1005161","DOI":"10.3389\/fimmu.2022.1005161","volume":"13","author":"J-Z Lin","year":"2022","unstructured":"Lin, J.-Z. et al. Myokine myostatin is a novel predictor of one-year radiographic progression in patients with rheumatoid arthritis: A prospective cohort study. Front. Immunol. 13, 1005161 (2022).","journal-title":"Front. Immunol."},{"key":"7378_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen, L.-K. et al. Asian Working Group for sarcopenia: 2019 Consensus Update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21, 300-307.e2 (2020).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"7378_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2010\/504078","volume":"2010","author":"AM Richards","year":"2010","unstructured":"Richards, A. M., Coleman, N. W., Knight, T. A., Belkoff, S. M. & Mears, S. C. Bone density and cortical thickness in normal, osteopenic, and osteoporotic sacra. J. Osteoporos. 2010, 1\u20135 (2010).","journal-title":"J. Osteoporos."},{"key":"7378_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.787228","volume":"8","author":"H Wu","year":"2021","unstructured":"Wu, H. et al. Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: A bibliometric analysis. Front. Med. 8, 787228 (2021).","journal-title":"Front. Med."},{"key":"7378_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10067-019-04787-9","volume":"39","author":"JJ Tong","year":"2020","unstructured":"Tong, J. J. et al. Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis. Clin. Rheumatol. 39, 357\u2013364 (2020).","journal-title":"Clin. Rheumatol."},{"key":"7378_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semarthrit.2020.10.002","volume":"51","author":"T-H Li","year":"2021","unstructured":"Li, T.-H. et al. The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis. Semin. Arthritis Rheum. 51, 236\u2013245 (2021).","journal-title":"Semin. Arthritis Rheum."},{"key":"7378_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-023-00921-9","volume":"19","author":"JL Bennett","year":"2023","unstructured":"Bennett, J. L., Pratt, A. G., Dodds, R., Sayer, A. A. & Isaacs, J. D. Rheumatoid sarcopenia: Loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat. Rev. Rheumatol. 19, 239\u2013251 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7378_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024186","volume":"100","author":"JD Murillo-Saich","year":"2021","unstructured":"Murillo-Saich, J. D. et al. Association of myostatin, a cytokine released by muscle, with inflammation in rheumatoid arthritis: A cross-sectional study. Medicine 100, e24186 (2021).","journal-title":"Medicine"},{"key":"7378_CR25","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1038\/s41598-021-93599-6","volume":"11","author":"M Fennen","year":"2021","unstructured":"Fennen, M. et al. A myostatin-CCL20-CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis. Sci. Rep. 11, 14145 (2021).","journal-title":"Sci. Rep."},{"key":"7378_CR26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha, D. & Smolen, J. S. Diagnosis and management of rheumatoid arthritis: A review. JAMA 320, 1360\u20131372 (2018).","journal-title":"JAMA"},{"key":"7378_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/bonekey.2016.48","volume":"5","author":"H Kaji","year":"2016","unstructured":"Kaji, H. Effects of myokines on bone. BoneKEy Rep. 5, 826 (2016).","journal-title":"BoneKEy Rep."},{"key":"7378_CR28","first-page":"702","volume":"63","author":"DP Lavrova","year":"2018","unstructured":"Lavrova, D. P. et al. Irisin as a new marker for the early diagnosis of low-traumatic fractures in rheumatoid arthritis. Klin Lab. Diagn. 63, 702\u2013706 (2018).","journal-title":"Klin Lab. Diagn."},{"key":"7378_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111443","volume":"127","author":"Y Yu","year":"2024","unstructured":"Yu, Y. et al. Irisin mitigates rheumatoid arthritis by suppressing mitochondrial fission via inhibiting YAP-Drp1 signaling pathway. Int. Immunopharmacol. 127, 111443 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"7378_CR30","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/jcmm.13438","volume":"22","author":"L Wu","year":"2018","unstructured":"Wu, L. et al. Relative abundance of mature myostatin rather than total myostatin is negatively associated with bone mineral density in Chinese. J. Cell. Mol. Med. 22, 1329\u20131336 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"7378_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028799","volume":"101","author":"JI Gamez-Nava","year":"2022","unstructured":"Gamez-Nava, J. I. et al. Serum irisin concentrations and osteoporotic vertebral fractures in women with rheumatoid arthritis: A cross-sectional study. Medicine 101, e28799 (2022).","journal-title":"Medicine"},{"key":"7378_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cen.12672","volume":"82","author":"A Palermo","year":"2015","unstructured":"Palermo, A. et al. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin. Endocrinol. 82, 615\u2013619 (2015).","journal-title":"Clin. Endocrinol."},{"key":"7378_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14397595.2018.1510565","volume":"29","author":"M Torii","year":"2019","unstructured":"Torii, M. et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod. Rheumatol. 29, 589\u2013595 (2019).","journal-title":"Mod. Rheumatol."},{"key":"7378_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jbspin.2018.08.001","volume":"86","author":"A Tournadre","year":"2019","unstructured":"Tournadre, A. et al. Sarcopenia. Jt. Bone Spine 86, 309\u2013314 (2019).","journal-title":"Jt. Bone Spine"},{"key":"7378_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.archger.2010.02.002","volume":"52","author":"M Di Monaco","year":"2011","unstructured":"Di Monaco, M., Vallero, F., Di Monaco, R. & Tappero, R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch. Gerontol. Geriat. 52, 71\u201374 (2011).","journal-title":"Arch. Gerontol. Geriat."},{"key":"7378_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/08977194.2011.599324","volume":"29","author":"M Elkasrawy","year":"2011","unstructured":"Elkasrawy, M., Fulzele, S., Bowser, M., Wenger, K. & Hamrick, M. Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression. Growth Factors 29, 253\u2013262 (2011).","journal-title":"Growth Factors"},{"key":"7378_CR37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/ijo.2014.42","volume":"38","author":"JY Huh","year":"2014","unstructured":"Huh, J. Y., Dincer, F., Mesfum, E. & Mantzoros, C. S. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int. J. Obes. 38, 1538\u20131544 (2014).","journal-title":"Int. J. Obes."},{"key":"7378_CR38","doi-asserted-by":"crossref","unstructured":"A, M. et al. Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90\u03b1.\u00a0Mol. Cell.\u00a083, 1903\u20131920 (2023).","DOI":"10.1016\/j.molcel.2023.05.008"},{"key":"7378_CR39","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cmet.2023.04.011","volume":"35","author":"W Wei","year":"2023","unstructured":"Wei, W. et al. Organism-wide, cell-type-specific secretome mapping of exercise training in mice. Cell Metab. 35, 1261\u20131279 (2023).","journal-title":"Cell Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07378-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07378-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:57:27Z","timestamp":1751410647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07378-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7378"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07378-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23068"}}